Copyright © 1993 by the European Society of Cardiology.
© 1993 The European Society of Cardiology
Evidence of oxidative stress in chronic heart failure in humans
Department of Cardiology, Western Infirmary Glasgow, Scotland
*Department of Chemistry, University of Strathclyde Glasgow, Scotland
Received 18 February 1993; revised 14 June 1993; .
Correspondence: Dr J. McMurray, Department of Cardiology, Western General Hospital, Edinburgh EH4 2XU, Scotland, U.K.
Abstract
Chronic heart failure (CHF) due to coronary artery disease (CAD) has been shown to be associated with increased plasma thiobarbituric reactive substances (TBARS) and reduced plasma thiol (PSH) concentrations, suggesting oxidative stress (OS). The aims of the present studies were (a) to determine whether OS is due to CAD or CHF per se and (b) to determine if a wider range of more specific markers of OS are abnormal in CHF.
In the first study, two groups of patients (n = 15 each) were compared. Group 1 (11 male, mean age 56 years) had CHF due to CAD and group 2 (12 male, mean age 53 years) had non-CAD CHF. Median plasma TBARS in controls was 7.6 nmol . ml1 , 10.0 nmol . m1 in group 1 and 9.3 nmol. ml1 in group 2 (P < 0.01 both groups vs control). Median PSH was 505 384 and 364 nmol. ml1 (P < 0.05 and P < 0.01 vs control) respectively.
Fifty-three patients with CHF were recruited in the second study. Malondialdehyde and PSH were 10.3 and 409 nmol. ml1 respectively, compared to control values of 7.9 and 560 nmol. ml.1 (both P < 0.001). The median values for the following additional measures of OS in controls and patients were: erythrocyte superoxide dismustase 131 vs 114 U . l1 (P = 0.005); caeruloplasmin oxidase 97 vs 197 U. l1 (P < 0.01); erythrocyte glutathione 1.56 nmol . ml1 vs 1.77 nmol . ml1 (P < 0.02); plasma conjugated dienes 0.28 vs 0.33 optical density units (P = ns).
Chronic heart failure, regardless of aetiology, is associated with abnormalities of a range of markers of OS.
Key Words: Oxidative stress free radicals chronic heart failure glutathione superoxide dismutase lipid peroxidation
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. Z. Simkhovich, M. T. Kleinman, and R. A. Kloner Air Pollution and Cardiovascular Injury: Epidemiology, Toxicology, and Mechanisms J. Am. Coll. Cardiol., August 26, 2008; 52(9): 719 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsutsumi, T. Ide, M. Yamato, W. Kudou, M. Andou, Y. Hirooka, H. Utsumi, H. Tsutsui, and K. Sunagawa Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction Cardiovasc Res, March 1, 2008; 77(4): 713 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Sharma, S. Dhingra, N. Khaper, and P. K. Singal Activation of apoptotic processes during transition from hypertrophy to heart failure in guinea pigs Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1384 - H1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Takimoto and D. A. Kass Role of Oxidative Stress in Cardiac Hypertrophy and Remodeling Hypertension, February 1, 2007; 49(2): 241 - 248. [Full Text] [PDF] |
||||
![]() |
T.B. Corcoran, A. Engel, H. Sakamoto, A. O'Shea, S. O'Callaghan-Enright, and G. D. Shorten The effects of propofol on neutrophil function, lipid peroxidation and inflammatory response during elective coronary artery bypass grafting in patients with impaired ventricular function Br. J. Anaesth., December 1, 2006; 97(6): 825 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Murdoch, M. Zhang, A. C. Cave, and A. M. Shah NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure Cardiovasc Res, July 15, 2006; 71(2): 208 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yano, S. Okuda, T. Oda, T. Tokuhisa, H. Tateishi, M. Mochizuki, T. Noma, M. Doi, S. Kobayashi, T. Yamamoto, et al. Correction of Defective Interdomain Interaction Within Ryanodine Receptor by Antioxidant Is a New Therapeutic Strategy Against Heart Failure Circulation, December 6, 2005; 112(23): 3633 - 3643. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Kevin, E. Novalija, and D. F. Stowe Reactive Oxygen Species as Mediators of Cardiac Injury and Protection: The Relevance to Anesthesia Practice Anesth. Analg., November 1, 2005; 101(5): 1275 - 1287. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Duncan, R. Ravi, L. B. Stull, and A. M. Murphy Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1512 - H1518. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Galinanes and A. G Fowler Role of clinical pathologies in myocardial injury following ischaemia and reperfusion Cardiovasc Res, February 15, 2004; 61(3): 512 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mak and G. E. Newton Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H789 - H795. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kameda, T. Matsunaga, N. Abe, H. Hanada, H. Ishizaka, H. Ono, M. Saitoh, K. Fukui, I. Fukuda, T. Osanai, et al. Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease: Possible role for left ventricular remodelling Eur. Heart J., December 2, 2003; 24(24): 2180 - 2185. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wagner, T. Seidler, E. Picht, L. S Maier, V. Kazanski, N. Teucher, W. Schillinger, B. Pieske, G. Isenberg, G. Hasenfuss, et al. Na+-Ca2+ exchanger overexpression predisposes to reactive oxygen species-induced injury Cardiovasc Res, November 1, 2003; 60(2): 404 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kogler, H. Fraser, S. McCune, R. Altschuld, and E. Marban Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium Cardiovasc Res, September 1, 2003; 59(3): 582 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
P A Henriksen and D E Newby Therapeutic inhibition of tumour necrosis factor {alpha} in patients with heart failure: cooling an inflamed heart Heart, January 1, 2003; 89(1): 14 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakamura, K. Kusano, Y. Nakamura, M. Kakishita, K. Ohta, S. Nagase, M. Yamamoto, K. Miyaji, H. Saito, H. Morita, et al. Carvedilol Decreases Elevated Oxidative Stress in Human Failing Myocardium Circulation, June 18, 2002; 105(24): 2867 - 2871. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Krum and J. J. McMurray Statins and chronic heart failure: do we need a large-scale outcome trial? J. Am. Coll. Cardiol., May 15, 2002; 39(10): 1567 - 1573. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsutsui, T. Tsutamoto, A. Wada, K. Maeda, N. Mabuchi, M. Hayashi, M. Ohnishi, and M. Kinoshita Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure J. Am. Coll. Cardiol., March 20, 2002; 39(6): 957 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Saavedra, N. Paolocci, M. E. St. John, M. W. Skaf, G. C. Stewart, J.-S. Xie, R. W. Harrison, J. Zeichner, D. Mudrick, E. Marban, et al. Imbalance Between Xanthine Oxidase and Nitric Oxide Synthase Signaling Pathways Underlies Mechanoenergetic Uncoupling in the Failing Heart Circ. Res., February 22, 2002; 90(3): 297 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mak and G. E. Newton The Oxidative Stress Hypothesis of Congestive Heart Failure : Radical Thoughts Chest, December 1, 2001; 120(6): 2035 - 2046. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rossig, J. Hoffmann, B. Hugel, Z. Mallat, A. Haase, J.-M. Freyssinet, A. Tedgui, A. Aicher, A. M. Zeiher, and S. Dimmeler Vitamin C Inhibits Endothelial Cell Apoptosis in Congestive Heart Failure Circulation, October 30, 2001; 104(18): 2182 - 2187. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Indik, S. Goldman, and M. A. Gaballa Oxidative stress contributes to vascular endothelial dysfunction in heart failure Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1767 - H1770. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Ennezat, S. L. Malendowicz, M. Testa, P. C. Colombo, A. Cohen-Solal, T. Evans, and T. H. LeJemtel Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymes J. Am. Coll. Cardiol., July 1, 2001; 38(1): 194 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Nightingale, D. J. Blackman, G. R. Ellis, M. Schmitt, J. A. Morris-Thurgood, E. A. Jones, and M. P. Frenneaux Preservation of venous endothelial function in the forearm venous capacitance bed of patients with chronic heart failure despite arterial endothelial dysfunction J. Am. Coll. Cardiol., March 15, 2001; 37(4): 1062 - 1068. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Nightingale, P. P. James, J. Morris-Thurgood, F. Harrold, R. Tong, S. K. Jackson, J. R. Cockcroft, and M. P. Frenneaux Evidence against oxidative stress as mechanism of endothelial dysfunction in methionine loading model Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1334 - H1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.C. Mendes Ribeiro, T.M.C. Brunini, J.C. Ellory, and G.E. Mann Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure Cardiovasc Res, March 1, 2001; 49(4): 697 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Ellis, R. A. Anderson, D. Lang, D. J. Blackman, R. H. K. Morris, J. Morris-Thurgood, I. F. W. McDowell, S. K. Jackson, M. J. Lewis, and M. P. Frenneaux Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1474 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Cohn, R. Ferrari, N. Sharpe, and on Behalf of an International Forum on Cardiac Rem Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling J. Am. Coll. Cardiol., March 1, 2000; 35(3): 569 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ide, H. Tsutsui, S. Kinugawa, H. Utsumi, D. Kang, N. Hattori, K. Uchida, K.-i. Arimura, K. Egashira, and A. Takeshita Mitochondrial Electron Transport Complex I Is a Potential Source of Oxygen Free Radicals in the Failing Myocardium Circ. Res., August 20, 1999; 85(4): 357 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kojda and D. Harrison Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure Cardiovasc Res, August 15, 1999; 43(3): 652 - 671. [Full Text] [PDF] |
||||
![]() |
M. L. Kukin, J. Kalman, R. H. Charney, D. K. Levy, C. Buchholz-Varley, O. N. Ocampo, and C. Eng Prospective, Randomized Comparison of Effect of Long-Term Treatment With Metoprolol or Carvedilol on Symptoms, Exercise, Ejection Fraction, and Oxidative Stress in Heart Failure Circulation, May 25, 1999; 99(20): 2645 - 2651. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Carlson and K. Oberg Clinical Pharmacology of Carvedilol Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(4): 205 - 218. [Abstract] [PDF] |
||||
![]() |
H. Ikenaga, N. Ishii, S. P. Didion, K. Zhang, K. G. Cornish, K. P. Patel, W. G. Mayhan, and P. K. Carmines Suppressed impact of nitric oxide on renal arteriolar function in rats with chronic heart failure Am J Physiol Renal Physiol, January 1, 1999; 276(1): F79 - F87. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Mallat, I. Philip, M. Lebret, D. Chatel, J. Maclouf, and A. Tedgui Elevated Levels of 8-iso-Prostaglandin F2{alpha} in Pericardial Fluid of Patients With Heart Failure : A Potential Role for In Vivo Oxidant Stress in Ventricular Dilatation and Progression to Heart Failure Circulation, April 28, 1998; 97(16): 1536 - 1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
E De Vecchi, M G Pala, G Di Credico, V Agape, G Paolini, P A Bonini, A Grossi, and R Paroni Relation between left ventricular function and oxidative stress in patients undergoing bypass surgery Heart, March 1, 1998; 79(3): 242 - 247. [Abstract] [Full Text] |
||||
![]() |
D. Yucel, S. Aydogdu, S. Cehreli, G. Saydam, H. Canatan, M. Senes, B. C. Topkaya, and S. Nebioglu Increased oxidative stress in dilated cardiomyopathic heart failure Clin. Chem., January 1, 1998; 44(1): 148 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Igarashi, M. Nishida, S. Hoshida, N. Yamashita, H. Kosaka, M. Hori, T. Kuzuya, and M. Tada Inducible nitric oxide synthase augments injury elicited by oxidative stress in rat cardiac myocytes Am J Physiol Cell Physiol, January 1, 1998; 274(1): C245 - C252. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Saavedra, N. Paolocci, M. E. St. John, M. W. Skaf, G. C. Stewart, J.-S. Xie, R. W. Harrison, J. Zeichner, D. Mudrick, E. Marban, et al. Imbalance Between Xanthine Oxidase and Nitric Oxide Synthase Signaling Pathways Underlies Mechanoenergetic Uncoupling in the Failing Heart Circ. Res., February 22, 2002; 90(3): 297 - 304. [Abstract] [Full Text] [PDF] |
||||














